Table 2.
Biochemical measures at baseline and after 6 months of treatment (mean ± SD).
| Test | Initial | Final |
| Fasting TG (mmol/L) | 1.97 ± 1.05 | 1.96 ± 0.63 |
| HDL (mmol/L) | 1.00 ± 0.30 | 0.93 ± 0.41 |
| LDL (mmol/L) | 2.18 ± 0.94 | 2.43 ± 0.91 |
| Total cholesterol (mmol/L) | 4.07 ± 0.81 | 4.26 ± 0.90 |
| WBISI | 2.2 ± 1.1 | 5.7 ± 8.1 |
| AUCins (pmol/L) | 2078.8 ± 668.8 | 1438.3 ± 988.5 |
| Adiponectin (mg/mL) | 10.01 ± 4.39 | 8.17 ± 3.46 |
| Leptin (ng/mL) | 27.64 ± 22.14 | 23.55 ± 25.34 |
| HbA1c (%) | 5.0 ± 0.3 | 4.8 ± 0.5 |
| AST (U/L) | 31.0 ± 6.95 | 30.4 ± 16.80 |
| ALT (U/L) | 28.3 ± 7.45 | 40.4 ±48.79 |
| Fasting glucose (mmol/L) | 4.4 ± 3.60 | 4.7 ± 0.69 |
| Fasting insulin (pmol/L) | 174.3 ± 87.79 | 130.2 ± 99.56 |
| 2 hour glucose (mmol/L) | 5.4 ± 0.96 | 6.2 ± 1.36 |
| 2 hour insulin (pmol/L) | 995.3 ± 531.19 | 735.0 ± 683.97 |
P value: not significant for all variables shown above. TG: triglycerides; HDL: high-density lipoprotein cholesterol; LDL: low-density lipoprotein cholesterol; WBISI: whole body insulin sensitivity index; AUCins: area-under-the-curve insulin; HbA1c: hemoglobin A1c; AST: aspartate aminotransferase; ALT: alanine aminotransferase.